(Q39635487)

13 September 2017

Identification of novel 5-hydroxy-1H-indole-3-carboxylates with anti-HBV activities based on 3D QSAR studies (English)

1 reference

13 September 2017

Hui-Fang Chai

1

1 reference

13 September 2017

Xin-Xia Liang

2

1 reference

13 September 2017

Lin Li

3

1 reference

13 September 2017

Chun-Shen Zhao

4

1 reference

13 September 2017

Ping Gong

5

1 reference

13 September 2017

Zhong-Jie Liang

6

1 reference

13 September 2017

Wei-Liang Zhu

7

1 reference

13 September 2017

Hua-Liang Jiang

8

1 reference

13 September 2017

Cheng Luo

9

1 reference

13 September 2017

30 October 2010

1 reference

Journal of Molecular Modeling

13 September 2017

1 reference

13 September 2017

17

1 reference

13 September 2017

8

1 reference

13 September 2017

1831-1840

1 reference

https://scigraph.springernature.com/pub.10.1007/s00894-010-0873-7

13 September 2017

0 references

cites work

Hepatitis B virus infection--natural history and clinical consequences

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0873-7

Result of endoscopic biliary drainage in hilar cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0873-7

Antivirals for the treatment of chronic hepatitis B: current and future options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0873-7

Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0873-7

Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 6-bromo-5-hydroxy-1H-indole-3-carboxylates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0873-7

Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 5-hydroxy-1H-indole-3-carboxylates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0873-7

Atomic Physicochemical Parameters for Three-Dimensional Structure-Directed Quantitative Structure-Activity Relationships I. Partition Coefficients as a Measure of Hydrophobicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0873-7

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0873-7

Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0873-7

Antisense oligonucleotides are effective inhibitors of hepatitis B virus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0873-7

Design, synthesis, and antihepatitis B virus activities of novel 2-pyridone derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0873-7

Anti-HBV agents. Part 2: synthesis and in vitro anti-hepatitis B virus activities of alisol A derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0873-7

Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21053034

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21053034

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00894-010-0873-7

1 reference

13 September 2017

1 reference